...the MATCH technology, is part of the company's streamlining activities following its merger with the Terrapin...

...which Ocera retains full rights. Ocera acquired the research facility through its merger with the Terrapin...

...shares. Canaccord Genuity is the sales agent. The program replaces a $45 million facility with Terrapin...

...Diego, Calif. Tranzyme Inc. , Durham, N.C. Business: Hepatic Ocera completed its merger with Tranzyme's Terrapin...

...The offering was concurrent with the merger of privately owned Ocera Therapeutics Inc. with the Terrapin...

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...

...Terrapin and Sanwa will use Terrapin's TRAP molecular fingerprinting technology to develop compounds to treat diabetes...
...active substances that lower blood glucose through their action on the insulin signal transduction pathway. Terrapin...
...investments, and is eligible for royalties. Sanwa receives commercialization rights in Japan and Asia, while Terrapin...

...the development of Terrapin's TER286 broad spectrum cancer compound. Taiho will provide R&D funding and Terrapin...
...to an IND, Taiho could obtain commercialization rights in Japan and possibly other Asian countries. Terrapin...
...a certain glutathione S-transferase (GST-P1) enzyme present in elevated amounts in many resistant solid tumors. Terrapin Technologies Inc....